Dr. Tim Larkin of Edward Hospital describes his weaning protocol for the Impella RP® during this physician Q&A session. In this session, Dr. Larkin explains the utility of the pulmonary artery pulsatility index for gauging appropriate weaning time for the Impella RP. Dr. Larkin also recommends monitoring serum lactate for assessing tissue perfusion prior to … Continue reading “Impella RP® Weaning Recommendations from Dr. Tim Larkin”
Key Takeaways Patients undergoing high-risk PCI often require additional hemodynamic support, particularly with the help of ventricular assist devices. There is no significant difference between Impella 2.5® and IABP in terms of bleeding risk and vascular complications. High-risk patients with acute coronary syndrome (ACS) often require additional cardiac support during a protected percutaneous coronary intervention … Continue reading “IABP vs Impella®: Incidence of Bleeding and Vascular Complications”
High-risk heart disease patients who present major abnormalities may be too weak for open-heart surgery; however, the utilization of certain techniques and devices may circumvent such medical challenges. Patients too weak for surgery who undergo a percutaneous coronary intervention (PCI), for example, have been treated in conjunction with the placement of Impella® . One case … Continue reading “Patients Too Weak for Surgery May Benefit from Heart Pumps”
Peripheral arterial disease (PAD), also referred to as hardening of the arteries, is a vascular disease that occurs in the arteries in the circulatory system. In PAD, the disease occurs in the arteries that carry oxygen and nutrient-rich blood from the heart to the arms and legs. For interventions that are aimed toward treating PAD or providing mechanical support, common femoral and brachial arteries are typical access sites for devices such as Impella® or intraaortic balloon pumps. Radial access does present its fair share of limitations, despite it becoming an increasingly popular access method among interventionalists. This synopsis of a recent article from the Journal of Invasive Cardiology provides a brief overview of the percutaneous insertion and removal of the Impella device using the axillary artery.The technique for insertion and removal of the Impella device using the axillary artery (AA) is as follows: Continue readingPercutaneous Insertion and Removal of Impella® Using the Axillary Artery for Treatment of Advanced Peripheral Artery Disease
Dr. Aaron Grantham of St. Luke’s Mid American Heart Institute shares an Impella case of an 80 year old woman with 3 vessel disease, moderate aortic stenosis, EF of 20% and 99% ostial calcified occlusion in RCA. Tweet this, subscribe or find educational opportunities near you.
High quality training for physicians on the use of Impella® devices is a key component of Abiomed’s Protected PCI™ program. The physician training program consists of two parts. The first part consists of a series of lectures conducted by Abiomed’s field team with hands-on instruction using the Automated Impella Controller. The lectures can be combined … Continue reading “Protected PCI Programs: Impella Training for Physicians”
The ProtectedPCI.com blogging team spoke with the Academic Medical Center’s Dr. Jose Henriques at the European Advanced Hemodynamic Course in Frankfort, Germany. Dr. Henriques has been using Impella from the first generation device and has recently published the European expert consensus document on Impella use in Europe. In this video he will discuss best practices … Continue reading “Impella Best Practices Based on 10 Years of Experience”
As part of our coverage and participation at this year’s TCT Conference, our employees are actively demonstrating the Impella catheter and how it can help elective and urgent high risk PCI patients that are hemodynamically stable presenting with severe coronary artery disease and depressed ejection fraction. Watch each short video below for more information.
Impella 2.5 Silicone Vascular Model Demonstration
Jo, a national trainer for Abiomed, demonstrates how the Impella catheter is placed into the heart. The demonstration uses a see-through silicone model, and the Impella catheter can be seen going into the aorta and across the aortic valve for correct placement. Physicians who learn to place the Impella catheter into the heart use similar models for training.
Impella 2.5 Placement Simulation
Jessica, the national nurse educator for Abiomed, explains the placement of the Impella catheter using fluoroscopy. She shows the effects of Impella placement on cardiac wave forms and blood pressures. The video demonstrates the hemodynamic changes that occur when hemodynamic support is provided by the Impella catheter-based heart pump.Continue readingAbiomed Team Demonstrates Impella at TCT 2015
Subscribe to the Digital Community
Receive weekly updates including case review videos, tips and tricks, specialists opinions, and resources and downloads regarding Protected PCI and Cardiogenic Shock.
Receive weekly updates including case review videos, tips and tricks, specialists opinions, and resources and downloads regarding Protected PCI and Cardiogenic Shock.
By completing this form, you are consenting to receiving emails regarding updates to the program, downloadable templates, case reviews, specialists opinions, and best practices.
Your personal information is important to us. Review our Privacy Policy and Terms of Use to learn how Abiomed protects your data.
